EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.
Bai Y, Chen L, Guo F, Zhang J, Hu J, Tao X, Lu Q, Li W, Chen X, Gong T, Qiu N, Jin Y, Yang L, Lei Y, Ruan C, Jing Q, Cooke JP, Wang S, Zou Y, Ge J.
Bai Y, et al. Among authors: qiu n.
Signal Transduct Target Ther. 2024 Nov 18;9(1):326. doi: 10.1038/s41392-024-02019-4.
Signal Transduct Target Ther. 2024.
PMID: 39557830
Free PMC article.